Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CRISPR-TILs |
Trade Name | |
Synonyms | |
Drug Descriptions |
CRISPR-TILs are autologous tumor infiltrating lymphocytes engineered to knockout PD-1 (PDCD1), which potentially induce tumor cell cytotoxicity (PMID: 35141398). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CRISPR-TILs | CRISPR-TILs | 0 | 1 |